Barrett & Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Sell |
2,840
-153
| -5% | -$5.88K | 0.04% | 199 |
|
|
2025
Q1 | $116K | Sell |
2,993
-118
| -4% | -$4.57K | 0.05% | 177 |
|
|
2024
Q4 | $105K | Buy |
3,111
+8
| +0.3% | +$271 | 0.04% | 191 |
|
|
2024
Q3 | $127K | Buy |
3,103
+9
| +0.3% | +$368 | 0.06% | 172 |
|
|
2024
Q2 | $119K | Sell |
3,094
-233
| -7% | -$8.97K | 0.05% | 175 |
|
|
2024
Q1 | $143K | Sell |
3,327
-392
| -11% | -$16.8K | 0.07% | 158 |
|
|
2023
Q4 | $138K | Sell |
3,719
-1,269
| -25% | -$47K | 0.07% | 151 |
|
|
2023
Q3 | $181K | Sell |
4,988
-1,573
| -24% | -$57K | 0.11% | 131 |
|
|
2023
Q2 | $234K | Sell |
6,561
-843
| -11% | -$30K | 0.14% | 114 |
|
|
2023
Q1 | $263K | Sell |
7,404
-824
| -10% | -$29.3K | 0.17% | 104 |
|
|
2022
Q4 | $289K | Hold |
8,228
| – | – | 0.19% | 96 |
|
|
2022
Q3 | $289K | Buy |
+8,228
| New | +$289K | 0.19% | 96 |
|